Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Unknown × Ovarian Neoplasms × Platinum Compounds × Clear all

Phase

Status

Completed 2 Unknown 1 Terminated 1 Not yet recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Carcinoma, Non-Small-Cell Lung 4 Stomach Neoplasms 2 Esophageal Neoplasms 2 Squamous-Cell Lung Cancer 1 Squamous Cell Carcinoma of Head and Neck 1 Pancreatic Neoplasms 1 Ovarian Neoplasms 1 Neoplasm Metastasis 1 Liver Neoplasms 1 Gallbladder Neoplasms 1 Fallopian Tube Neoplasms 1 Colonic Neoplasms 1 Biliary Tract Neoplasms 1 Adenocarcinoma of Lung 1

Interventions

Carboplatin 35 Paclitaxel 34 Bevacizumab 13 olaparib 12 niraparib 11 apatinib 11 Cisplatin 10 liposomal doxorubicin 9 Gemcitabine 9 Cyclophosphamide 8 fludarabine 7 Hyperthermic Intraperitoneal Chemotherapy 7 Etoposide 7 pembrolizumab 6 Topotecan 5 Drug Therapy 5 fluzoparib 4 anlotinib 4 Surveys and Questionnaires 4 Ifosfamide 4 Doxorubicin 4 Docetaxel 4 Albumin-Bound Paclitaxel 4 oregovomab 3 Taxes 3 Poly(ADP-ribose) Polymerase Inhibitors 3 Cytoreduction Surgical Procedures 3 Amplified Fragment Length Polymorphism Analysis 3 1-dodecylpyridoxal 3 pazopanib 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02489006 2024-01-17

NEO

University Health Network, Toronto

Phase 2 Unknown

Fallopian Tube Neoplasms, Ovarian Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡